Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (Nasdaq: CRXL) announced that JNJ will acquire all outstanding shares of CRXL ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE